Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Womens Health Issues. 2018 Nov 3;29(1):38–47. doi: 10.1016/j.whi.2018.09.006

Table 2.

Characteristics, by study group, of perceived susceptibility to cervical cancer

Un/under-screened Screened Colposcopy
Yes n=42 No n=28 DK n=90 P a Yes n=56 No n=37 DK n=105 P a Yes n=66 No n=33 DK n=67 P a
Ageb 37.1 (8.0) 39.1 (8.8) 41.7 (9.4) .02 35.2 (8.3) 34.7 (7.5) 34.4 (7.3) .80 31.4 (6.5) 34.2 (8.0) 31.3 (6.3) .09
Education (y)b 12.0 (2.4) 12.7 (2.1) 11.8 (1.9) .13 12.5 (2.3) 12.2 (2.5) 12.9 (2.4) .20 12.6 (2.2) 12.5 (2.0) 12.2 (2.6) .64
Married/cohabitatec 13 (31.0) 4 (14.3) 30 (33.3) .15 22 (39.3) 15 (40.5) 26 (25.0) .08 21 (31.8) 7 (21.2) 17 (25.4) .49
Sexual initiation (y)b 15.1 (2.5) 16.4 (2.7) 16.8 (3.7) .02 15.7 (2.7) 16.8 (4.0) 16.6 (2.6) .13 15.9 (3.0) 16.9 (2.6) 17.0 (2.7) .06
Lifetime partners (#)b 11.4 (10.5) 6.7 (5.1) 8.2 (8.3) .06 9.6 (8.9) 6.5 (5.1) 8.5(7.8) .17 10.1 (9.0) 7.2 (5.5) 8.9 (14.5) .47
Income/month 1137 1040 1025 .63 1456 1687 1347 .67 1286 1213 1278 .92
(US$)b (752) (491) (568) (1429) (2265) (1995) (913) (775) (785)
How often do you visit the doctor when sickc
 Always 13 (31.0) 7 (25.0) 19 (21.1) 20 (35.7) 8 (21.6) 28 (26.7) 23 (34.9) 17 (51.5) 18 (26.9)
 Sometimes 20 (47.6) 14 (50.0) 49 (54.4) .90 33 (58.9) 26 (70.3) 62 (59.1) .36 34 (51.5) 9 (27.3) 41 (61.2) .04
 Never 4 (9.6) 4 (14.3) 13 (14.4) 1(1.8) 2 (5.4) 4 (3.8) 5 (7.6) 2 (6.1) 2 (3.0)
 Not sick 5 (11.9) 3 (10.7) 9(10.0) 2(3.6) 1(2.7) 11(10.5) 4 (6.1) 5 (15.2) 6 (9.0)
Pap Recommendationc 11 (26.2) 3(10.7) 22(24.4) .25 16 (28.6) 7 (18.9) 13 (12.4) .04 22 (33.3) 8 (24.2) 15 (22.4) .34
Family historyc 27 (64.3) 14 (50.0) 49 (54.4) .44 42 (75.0) 16 (43.2) 49 (46.7) <.01 50 (75.8) 15 (45.5) 39 (58.2) <.01
Perceived seriousness of cervical cancerc
 Slight/moderate 1 (2.4) 3 (10.7) 3 (3.3) 0 (0.0) 1 (2.7) 1 (0.9) 2 (3.0) 1 (3.0) 3 (4.5)
 Serious 10 (23.8) 4 (14.3) 28 (31.1) .27 10 (17.9) 10 (27.0) 21 (20.0) .12 15 (22.7) 9 (27.3) 19 (28.3) .40
 Extreme 30 (71.4) 20 (71.4) 58 (64.5) 46 (82.1) 24 (64.9) 74 (70.5) 49 (74.2) 23 (69.7) 41 (61.2)
 DK 1 (2.4) 1 (3.6) 1 (1.1) 0 (0.0) 2 (5.4) 9 (8.6) 0 (0.0) 0 (0.0) 4 (6.0)
Perceived prior HPV exposurec
 No 15 (35.7) 19 (67.9) 26 (28.9) 14 (25.0) 29 (78.4) 31 (29.5) <.01 12 (18.2) 18 (54.6) 21 (17.9)
 Yes 6 (14.3) 0 (0.0) 0 (0.0) <.01 18 (32.1) 0 (0.0) 6 (5.7) 22 (33.3) 7 (21.2) 10 (14.9) <.01
 DK 21 (50.0) 9 (32.1) 64 (71.1) 24 (42.9) 8 (21.6) 68 (64.8) 32 (48.5) 8 (24.2) 45 (67.2)

Abbreviations: DK, I don’t know; Sexual initation, age at first intercourse; Lifetime partners: lifetime sexual partners; Family history:

cancer-related death; Pap recommendation: Provider recommendation in past year; HPV: Human Papillomavirus

a

ANOVA for continuous variables, Pearson χ2 for categorical variables, and Exact P-value for categorical variables with cell size ≤ 5

b

Mean (standard deviation)

c

n (%)